Trial Profile
An Open-Label, Two-Period, Single Sequence, Cross-Over, Drug-Drug Interaction Study to Evaluate the Effect of Multiple Dose Erythromycin on the Pharmacokinetics of GRC 17536 After a Single Dose in Healthy Male Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Jul 2019
Price :
$35
*
At a glance
- Drugs ISC 17536 (Primary) ; Erythromycin
- Indications Allergic asthma; Cough; Neuropathic pain
- Focus Pharmacokinetics
- Sponsors Glenmark Pharmaceuticals S.A.
- 17 Jun 2019 Status changed from active, no longer recruiting to completed, as reported in India Clinical Trials Register record.
- 01 Sep 2016 New trial record